CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: A randomized clinical trial
- 31 January 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (2) , 175-179
- https://doi.org/10.1016/0277-5379(85)90169-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP ChemotherapyAnnals of Internal Medicine, 1983
- Cyclophosphamide, Vincristine, Methotrexate with Leucovorin Rescue, and Cytarabine (COMLA) Combination Sequential Chemotherapy for Advanced Diffuse Histiocytic LymphomaAnnals of Internal Medicine, 1980
- Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group studyCancer, 1979
- 5-YEAR SURVEY OF METHOTREXATE, CYCLOPHOSPHAMIDE (ENDOXAN), AND VINCRISTINE (MEV) THERAPY FOR ADVANCED NON-HODGKINS LYMPHOMAS1978
- Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphomaBlood, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- COMBINATION CHEMOTHERAPY (CHOP-BLEO) IN ADVANCED (NON-HODGKIN) MALIGNANT-LYMPHOMA1977
- COMBINATION CHEMOTHERAPY OF ADVANCED NON-HODGKIN LYMPHOMA WITH BLEOMYCIN, ADRIAMYCIN, CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE (BACOP)1977
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASEThe Lancet, 1975